Aberrant ALK activity has been strongly implicated in the oncogenesis of human cancer as a fusion protein in inflammatory myofibroblastic tumors, diffuse large B-cell lymphoma and anaplastic large-cell lymphoma, or through mutations in the full-length protein in hereditary familial neuroblastoma [18–22]. This evidence concerns the gene ALK and cancer.